Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4HPJ0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.519 |
CLV_NRD_NRD_1 | 249 | 251 | PF00675 | 0.366 |
CLV_PCSK_KEX2_1 | 134 | 136 | PF00082 | 0.529 |
CLV_PCSK_KEX2_1 | 226 | 228 | PF00082 | 0.419 |
CLV_PCSK_PC1ET2_1 | 134 | 136 | PF00082 | 0.542 |
CLV_PCSK_PC1ET2_1 | 226 | 228 | PF00082 | 0.360 |
CLV_PCSK_SKI1_1 | 180 | 184 | PF00082 | 0.333 |
CLV_PCSK_SKI1_1 | 226 | 230 | PF00082 | 0.476 |
CLV_PCSK_SKI1_1 | 91 | 95 | PF00082 | 0.333 |
DEG_APCC_DBOX_1 | 253 | 261 | PF00400 | 0.470 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.537 |
DOC_ANK_TNKS_1 | 139 | 146 | PF00023 | 0.420 |
DOC_PP1_RVXF_1 | 132 | 139 | PF00149 | 0.444 |
DOC_PP4_MxPP_1 | 217 | 220 | PF00568 | 0.624 |
DOC_USP7_MATH_1 | 119 | 123 | PF00917 | 0.403 |
DOC_USP7_MATH_1 | 143 | 147 | PF00917 | 0.413 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.559 |
DOC_USP7_MATH_1 | 253 | 257 | PF00917 | 0.619 |
DOC_USP7_MATH_1 | 54 | 58 | PF00917 | 0.531 |
DOC_USP7_UBL2_3 | 226 | 230 | PF12436 | 0.504 |
LIG_APCC_ABBA_1 | 19 | 24 | PF00400 | 0.534 |
LIG_BRCT_BRCA1_1 | 2 | 6 | PF00533 | 0.630 |
LIG_FHA_1 | 111 | 117 | PF00498 | 0.238 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.334 |
LIG_FHA_1 | 195 | 201 | PF00498 | 0.615 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.591 |
LIG_FHA_1 | 61 | 67 | PF00498 | 0.557 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.565 |
LIG_FHA_2 | 239 | 245 | PF00498 | 0.627 |
LIG_FHA_2 | 293 | 299 | PF00498 | 0.731 |
LIG_LIR_Apic_2 | 49 | 54 | PF02991 | 0.525 |
LIG_LIR_Gen_1 | 110 | 119 | PF02991 | 0.342 |
LIG_LIR_Nem_3 | 27 | 33 | PF02991 | 0.510 |
LIG_LIR_Nem_3 | 49 | 53 | PF02991 | 0.547 |
LIG_LIR_Nem_3 | 85 | 90 | PF02991 | 0.522 |
LIG_MLH1_MIPbox_1 | 2 | 6 | PF16413 | 0.630 |
LIG_Pex14_1 | 107 | 111 | PF04695 | 0.574 |
LIG_SH2_CRK | 87 | 91 | PF00017 | 0.499 |
LIG_SH2_CRK | 92 | 96 | PF00017 | 0.487 |
LIG_SH2_GRB2like | 50 | 53 | PF00017 | 0.513 |
LIG_SH2_PTP2 | 72 | 75 | PF00017 | 0.526 |
LIG_SH2_SRC | 72 | 75 | PF00017 | 0.426 |
LIG_SH2_STAT5 | 198 | 201 | PF00017 | 0.525 |
LIG_SH2_STAT5 | 224 | 227 | PF00017 | 0.696 |
LIG_SH2_STAT5 | 5 | 8 | PF00017 | 0.567 |
LIG_SH2_STAT5 | 59 | 62 | PF00017 | 0.575 |
LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.484 |
LIG_SH3_3 | 209 | 215 | PF00018 | 0.604 |
LIG_TRAF2_1 | 220 | 223 | PF00917 | 0.626 |
LIG_TYR_ITIM | 90 | 95 | PF00017 | 0.493 |
LIG_WRC_WIRS_1 | 128 | 133 | PF05994 | 0.532 |
LIG_WRC_WIRS_1 | 148 | 153 | PF05994 | 0.449 |
MOD_Cter_Amidation | 131 | 134 | PF01082 | 0.507 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.251 |
MOD_GlcNHglycan | 24 | 29 | PF01048 | 0.404 |
MOD_GlcNHglycan | 303 | 306 | PF01048 | 0.491 |
MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.349 |
MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.333 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.361 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.413 |
MOD_N-GLC_1 | 114 | 119 | PF02516 | 0.363 |
MOD_NEK2_1 | 114 | 119 | PF00069 | 0.145 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.372 |
MOD_NEK2_1 | 60 | 65 | PF00069 | 0.533 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.534 |
MOD_NEK2_1 | 94 | 99 | PF00069 | 0.512 |
MOD_PKA_2 | 253 | 259 | PF00069 | 0.615 |
MOD_PKA_2 | 301 | 307 | PF00069 | 0.613 |
MOD_Plk_1 | 114 | 120 | PF00069 | 0.348 |
MOD_Plk_4 | 143 | 149 | PF00069 | 0.342 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.449 |
MOD_SUMO_rev_2 | 204 | 208 | PF00179 | 0.636 |
MOD_SUMO_rev_2 | 76 | 81 | PF00179 | 0.595 |
TRG_DiLeu_BaLyEn_6 | 244 | 249 | PF01217 | 0.551 |
TRG_ENDOCYTIC_2 | 109 | 112 | PF00928 | 0.476 |
TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.517 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.517 |
TRG_ENDOCYTIC_2 | 72 | 75 | PF00928 | 0.522 |
TRG_ENDOCYTIC_2 | 87 | 90 | PF00928 | 0.453 |
TRG_ENDOCYTIC_2 | 92 | 95 | PF00928 | 0.360 |
TRG_ER_diArg_1 | 133 | 136 | PF00400 | 0.360 |
TRG_NLS_MonoExtC_3 | 225 | 230 | PF00514 | 0.502 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P459 | Leptomonas seymouri | 83% | 100% |
A0A0S4JIL7 | Bodo saltans | 50% | 100% |
A0A1X0P3F8 | Trypanosomatidae | 61% | 100% |
A0A3R7NG42 | Trypanosoma rangeli | 63% | 100% |
A0A3S5H831 | Leishmania donovani | 88% | 100% |
A4ID73 | Leishmania infantum | 90% | 100% |
D0A8F4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9ATA2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4Q195 | Leishmania major | 90% | 100% |
V5BIN2 | Trypanosoma cruzi | 59% | 100% |